Additional file 1: of Physical activity and nutrition intervention for Singaporean women aged 50 years and above: study protocol for a randomised controlled trial

SPIRIT 2013 Checklist: recommended items to address in a clinical trial protocol and related documents. (DOC 127 kb

Additional file 4: of Physical activity and nutrition intervention for Singaporean women aged 50 years and above: study protocol for a randomised controlled trial

Health survey: Mandarin. (PDF 553 kb

Additional file 3: of Physical activity and nutrition intervention for Singaporean women aged 50 years and above: study protocol for a randomised controlled trial

Health survey: English. (PDF 318 kb

Additional file 2: of Physical activity and nutrition intervention for Singaporean women aged 50 years and above: study protocol for a randomised controlled trial

Stratified cluster random sampling of the 5 major districts in Singapore for the physical activity (PA) and nutrition intervention. (DOC 169 kb

Antipsychotic medication compared with placebo at post-treatment—weight.

<p>Antipsychotic medication compared with placebo at post-treatment—weight.</p

PRISMA flowchart.

<p>PRISMA flowchart.</p

Antipsychotic medication compared with placebo at post-treatment—total symptoms.

<p>Antipsychotic medication compared with placebo at post-treatment—total symptoms.</p

Family plus individual CBT compared with TAU at EPPIC—Time to relapse at post-treatment.

<p>Family plus individual CBT compared with TAU at EPPIC—Time to relapse at post-treatment.</p

Study characteristics for pharmacological interventions.

<p><i>Note</i>.</p><p>* Data not reported in sufficient detail to include in analysis</p><p>¹ Molindone was the third arm of this trial (n = 40), however as it was discontinued by its sole supplier, Endo Pharmaceuticals, on January 13, 2010, only data for risperidone and olanzapine are used in this review</p><p>² The study design consisted of an 8 week ‘acute phase’ and a blind ‘maintenance phase’ up to 52 weeks post randomization. During the maintenance phase participants continued to be administered treatment within their randomised groups and at same dose range.</p><p>³ Loxapine was the third arm of this trial (n = 26), however it was not included in this guideline as it was discontinued in the UK in 2003.</p><p>⁴This trial included a fourth arm of paliperidone 6–12mg/day. The 3–6mg/day arm was selected as the ‘higher dose’ antipsychotic medication in accordance with POMH-UK Topic 10 benchmarking exercise and therefore the 6–12mg/day arm was not included in the current work.</p><p>N = number randomised; nr = not reported; na = not applicable; mg = milligrams; DU = duration of treatment; PT = post-treatment data collection; FU = follow-up data collection</p><p>Study characteristics for pharmacological interventions.</p

Ctenitis lepigera Tagawa

原著和名: キンマウヰノデ科名: オシダ科 = Dryopteridaceae採集地: 東京都 小笠原村 母島 (小笠原村 母島)採集日: 1970/6/13採集者: 萩庭丈壽整理番号: JH047750国立科学博物館整理番号: TNS-VS-99775